title: Cancer survival: global surveillance will stimulate health policy and improve equity.
abstract: Millions of people will continue to be diagnosed with cancer every year for the foreseeable future. These patients all need access to optimum health care. Population-based cancer survival is a key measure of the overall effectiveness of health systems in management of cancer. Survival varies very widely around the world. Global surveillance of cancer survival is needed, because unless these avoidable inequalities are measured, and reported on regularly, nothing will be done explicitly to reduce them.
authors.affiliation: Cancer Research UK Cancer Survival Group, Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK. Electronic address: michel.coleman@lshtm.ac.uk.
authors.forename: Michel P
authors.initials: MP
authors.lastname: Coleman
mesh_terms: D000328:Adult; D000368:Aged; D017281:Cost of Illness; D014943:Global Health; D006285:Health Planning / Q000458:organization & administration; D006291:Health Policy; D006297:Health Services Accessibility / Q000458:organization & administration / Q000592:standards; D054625:Healthcare Disparities; D006801:Humans; D007391:International Cooperation; D008875:Middle Aged; D061213:Mortality, Premature; D009369:Neoplasms / Q000401:mortality* / Q000517:prevention & control; D062486:Public Health Surveillance; D016019:Survival Analysis